Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gema, Ramirez
NCT01491763: Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE	Recruiting	4	70	Europe	Imatinib	PETHEMA Foundation	Acute Lymphoblastic Leukemia Ph Positive	12/22	12/22
José, Moreno Mª
NCT01491763: Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE	Recruiting	4	70	Europe	Imatinib	PETHEMA Foundation	Acute Lymphoblastic Leukemia Ph Positive	12/22	12/22
PETHEMA LAL-07FRAIL , NCT01358201: PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years	Recruiting	4	100	Europe	vINCRISTINE, Dexamethasone, Methotrexate, Cytosine arabinoside	PETHEMA Foundation	Acute Lymphoblastic Leukemia	12/22	12/22
Ramirez, Gema
NCT01491763: Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE	Recruiting	4	70	Europe	Imatinib	PETHEMA Foundation	Acute Lymphoblastic Leukemia Ph Positive	12/22	12/22